November 17, 2009 / 4:40 AM / 10 years ago

India's Sun Pharma gets tentative ok for Gleevec generic

MUMBAI, Nov 17 (Reuters) - India’s Sun Pharma (SUN.BO) said on Tuesday the U.S. Food and Drug Administration has given tentative approval for its generic version of Novartis’ NOVN.VX Gleevec, used to treat leukemia. (Reporting by Jeanette Rodrigues; Editing by Anshuman Daga)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below